Delivery Order SPE2DE21D0007-SPE2D625F1C7B
Award Date
4/3/25
Potential Completion Date
4/7/25
Potential Value
$5.3K
Federal Agency
Medical Supply Chain
Awardee
Ortho-Clinical Diagnostics, Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DE21D0007|SPE2D625F1R4B, was issued by the Medical Supply Chain, a component of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,832.54 fixed-price contract with economic price adjustment is for the delivery of "ANTI-A BIOCLONE 15X10ML" medical supplies. This appears to be a delivery order under a larger contract vehicle, as the award notice references Ortho-Clinical...
This federal contract award (SPE2DE21D0007|SPE2D625F7R49) was issued by the Medical Supply Chain organization within the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture located in Raritan, New Jersey. The $1,994.20 fixed-price with economic price adjustment delivery order is for the supply of "ANTI-JKA BIOCLONE 1X3ML" medical products, with a performance period ending on March 25, 2025. The...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $1,524.24, is for the delivery of 4563969866 SERUM ANTI D 10ML 3S. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and has an ultimate completion date of April 3, 2024. The contract does not have a set-aside designation. Ortho-Clinical...
This is a $1,994.20 fixed-price delivery order awarded by the Defense agency Medical Supply Chain to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The award is for the supply of "ANTI-JKA BIOCLONE 1X3ML", a specialized medical diagnostic product. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture and holds multiple federal contract vehicles, including indefinite delivery contracts and blanket purchase...
This is a federal delivery order contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The contract is for the supply of Anti-A Bioclone 15x10ml, a critical medical diagnostic product, with a ceiling value of $1,832.54 and a period of performance through March 25, 2025. The contract is a fixed-price agreement with economic price adjustment and does not have a set-aside designation,...
This federal contract award to Ortho-Clinical Diagnostics, Inc., a self-certified HUBZone joint venture manufacturer, was issued by the Medical Supply Chain division of the Defense Logistics Agency. The $2,869.77 firm-fixed-price delivery order is for the supply of 150 ml bottles of Reagent Anti-D Bioclone, a critical medical reagent. The contract has an ultimate completion date of October 3, 2024. Ortho-Clinical Diagnostics has previously provided a range of medical equipment, reagents, and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for $71,850.72. The contract has an estimated completion date of April 30, 2025 and does not have a set-aside designation. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture that provides a range of diagnostic solutions, including COVID-19 tests and immunodiagnostic systems, to federal...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Defense Health Agency (DHA). The contract, valued at $2,156.03, is a Delivery Order for the supply of Anti-SM E Bioclone 1x5ml, a critical medical diagnostic product. The contract has a period of performance ending on February 18, 2025. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and manufacturer of goods based in Raritan, New Jersey. The...
This contract was awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The firm fixed price contract, valued at $63,640.26, is for the delivery of unspecified "other medical" products. The contract does not have a set-aside designation and is scheduled to be completed by April 30, 2024. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture that has provided a range of medical...
This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer registered in SAM.gov. The contract is for the delivery of 4567683435 ! ANTI-B BIOCLONE 15X10ML products, with a completion date of March 27, 2025. This appears to be a delivery order contract with a fixed price with economic price adjustment pricing type. The contract does not utilize any...